This article is part of the Thematic Series \"Multicomponent reactions II\".

Introduction
============

Fluorine-containing compounds play an important role in medicinal and pharmaceutical chemistry as well as in agrochemistry \[[@R1]--[@R4]\]. A popular approach for the modulation of activity consists in the introduction of one or more fluorine atoms into the structure of a bioactive compound. This variation frequently leads to a higher metabolic stability and can modulate some physicochemical properties such as basicity or lipophilicity \[[@R1]--[@R2]\]. Moreover, incorporation of fluorine often results in an increase of the binding affinity of drug molecules to the target protein \[[@R1]--[@R2]\]. As a consequence, a considerable amount -- approximately 20% -- of all the pharmaceuticals being currently on the market contain at least one fluorine substituent, including important drug molecules in different pharmaceutical classes \[[@R5]\]. Keeping in mind the above facts, the synthesis of fluorinated heterocyclic compounds, which can act as building blocks for the construction of biologically active fluorine-containing molecules, is of eminent interest. In the field of pyrazoles, pyridines and condensed systems thereof trifluoromethyl-substituted congeners can be found as partial structures in several pharmacologically active compounds. In the pyridine series the HIV protease inhibitor Tipranavir (Aptivus^®^) \[[@R6]\] may serve as an example, within the pyrazole-derived compounds the COX-2 inhibitor Celecoxib (Celebrex^®^) is an important representative ([Fig. 1](#F1){ref-type="fig"}) \[[@R7]\].

![Important drug molecules containing a trifluoromethylpyridine, respectively a trifluoromethylpyrazole moiety.](Beilstein_J_Org_Chem-10-1759-g002){#F1}

In continuation of our program regarding the synthesis of fluoro- and trifluoromethyl-substituted pyrazoles and annulated pyrazoles \[[@R8]--[@R9]\] we here present the synthesis of trifluoromethyl-substituted pyrazolo\[4,3-*c*\]pyridines. The latter heterocyclic system represents the core of several biologically active compounds, acting, for instance, as SSAO inhibitors \[[@R10]\], or inhibitors of different kinases (LRRK2 \[[@R11]--[@R12]\], TYK2 \[[@R13]\], JAK \[[@R14]--[@R15]\]).

Results and Discussion
======================

Chemistry
---------

The construction of the pyrazolo\[4,3-*c*\]pyridine system can be mainly achieved through two different approaches. One strategy involves the annelation of a pyrazole ring onto an existing, suitable pyridine derivative \[[@R16]\]. Alternatively, the bicyclic system can be accessed by pyridine-ring formation with an accordant pyrazole precursor. Employing the latter approach we recently presented a novel method for the synthesis of the pyrazolo\[4,3-*c*\]pyridine system by Sonogashira-type cross-coupling reaction of easily obtainable 5-chloro-1-phenyl-1*H*-pyrazole-4-carbaldehydes with various alkynes and subsequent ring-closure reaction of the thus obtained 5-alkynyl-1*H*-pyrazole-4-carbaldehydes in the presence of *tert*-butylamine \[[@R17]\]. Furthermore, we showed that the oximes derived from the before mentioned 5-alkynylpyrazole-4-carbaldehydes can be transformed into the corresponding 1-phenylpyrazolo\[4,3-*c*\]pyridine 5-oxides \[[@R17]\].

For the synthesis of the title compounds a similar approach was envisaged. As starting material the commercially available 1-phenyl-3-trifluoromethyl-1*H*-pyrazol-5-ol (**1**) was employed which, after Vilsmaier formylation \[[@R18]\] and concomitant transformation of the hydroxy function into a chloro substituent by treatment with excessive POCl~3~, gave the chloroaldehyde **2** \[[@R19]\] ([Scheme 1](#C1){ref-type="fig"}). Although Sonogashira-type cross-coupling reactions are preferably accomplished with iodo(hetero)arenes -- considering the general reactivity I \> Br/OTf \>\> Cl \[[@R20]\] -- from related examples it was known that the chloro atom in 5-chloropyrazole-4-aldehydes is sufficiently activated to act as the leaving group in such kind of C--C linkages \[[@R17]\]. Indeed, reaction of chloroaldehyde **2** with different alkynes **3a**--**c** under typical Sonogashira reaction conditions afforded the corresponding cross-coupling products **4a**--**c** in good yields ([Scheme 1](#C1){ref-type="fig"}). In some runs compounds of type **8** were determined as byproducts in differing yields, but mostly below 10%, obviously resulting from addition of water to the triple bond of **4** under the reaction conditions (or during work-up) and subsequent tautomerization of the thus formed enoles into the corresponding ketones. The hydration of C--C triple bonds under the influence of various catalytic systems, including also Pd-based catalysts, is a well-known reaction \[[@R21]--[@R22]\]. It should be emphasized that NMR investigations with compounds **8a**,**c** unambiguously revealed the methylene group adjacent to the pyrazole nucleus and the carbonyl moiety attached to the substituent R originating from the employed alkyne.

![Synthesis of the title compounds.](Beilstein_J_Org_Chem-10-1759-g004){#C1}

In the next reaction step, alkynylaldehydes **4a**,**b** were cyclized into the target pyrazolo\[4,3-*c*\]pyridines **5a**,**b** in 71%, resp. 52% yield by reaction with *tert*-butylamine under microwave assistance \[[@R17]\]. In view of the fact, that the two-step conversion **2**→**4a**,**b**→**5a**,**b** was characterized by only moderate overall yields (59%, resp. 43%) it was considered to merge these two steps into a one-pot multicomponent reaction. The latter type of reaction attracts increasing attention in organic chemistry due to its preeminent synthetic efficiency, also in the construction of heterocyclic and condensed heterocyclic systems \[[@R23]--[@R27]\]. After testing different reaction conditions we found that microwave heating of the chloroaldehyde **2** with *tert*-butylamine in the presence of 6 mol % of Pd(PPh~3~)~2~Cl~2~ afforded the desired pyrazolopyridines **5a**--**c** in high (**5a**: 89%, **5c**: 92%) respectively acceptable yields (**5b**: 51%) in a single one-pot and copper-free reaction step ([Scheme 1](#C1){ref-type="fig"}). It should be mentioned that compounds **5** are also accessible by heating of ketones **8** with ammonium acetate in acetic acid according to a procedure described in \[[@R28]\]. Following this way, **5a** and **5c** were obtained in 70% yield from the corresponding ketones **8a** and **8c**. Although ketones **8** were only obtained as byproducts, the latter transformation allowed increasing the overall yield of compounds **5** through this 'bypass'.

In order to gain access to the corresponding *N*-oxides of type **7**, aldehydes **4a**--**c** were transformed into the corresponding oximes **6a**--**c** by reaction with hydroxylamine hydrochloride in ethanol in the presence of sodium acetate ([Scheme 1](#C1){ref-type="fig"}). Subsequent treatment of the oximes with AgOTf in dichloromethane \[[@R29]\] finally afforded the corresponding pyrazolo\[4,3-*c*\]pyridine 5-oxides **7a**--**c** by a regioselective 6-*endo-dig* cyclisation \[[@R30]\] in high yields. Moreover, we tested an alternative approach to access compounds **7** through multicomponent reactions (MCR). Attempts to react chloroaldehyde **2** with hydroxylamine hydrochloride and an alkyne **3** in the presence of a suitable catalytic system were not successful. However, after conversion of **2** into the corresponding aldoxime **9** the latter could be transformed into the *N*-oxides **7a** and **7b** by reaction with alkynes **3a** and **3b**, respectively, employing Pd(OAc)~2~ as the catalyst and under microwave irradiation ([Scheme 1](#C1){ref-type="fig"}). Although a number of different reaction conditions were tested, we were not able to increase the yields in excess of 30%. Thus, with respect to the overall yields the successive approach **2**→**4**→**6**→**7** (overall yields: **6a**: 62%, **6b**: 43%) here is still advantageous compared to the multicomponent reaction following the path **2**→**9**→**7**. Azine *N*-oxides of type **7** are estimated to be of particular interest due to the possibility of further functionalization adjacent to the nitrogen atom (position 4), for instance by palladium-catalyzed direct arylation reactions \[[@R31]\].

NMR spectroscopic investigations
--------------------------------

In [Supporting Information File 1](#SD1){ref-type="supplementary-material"} the NMR spectroscopic data of all compounds treated within this study are indicated. Full and unambiguous assignment of all ^1^H, ^13^C, ^15^N and ^19^F NMR resonances was achieved by combining standard NMR techniques \[[@R32]\], such as fully ^1^H-coupled ^13^C NMR spectra, APT, HMQC, gs-HSQC, gs-HMBC, COSY, TOCSY, NOESY and NOE-difference spectroscopy.

In compounds **4**--**7** the trifluoromethyl group exhibits very consistent chemical shifts, ranging from δ(F) −60.8 to −61.9 ppm. The fluorine resonance is split into a doublet by a small coupling (0.5--0.9 Hz) due to a through-space (or possibly ^5^ *J*) interaction with spatially close protons (**4**: CHO; **6**: CH=N; **5** and **7**: H-4). Reversely, the signals of the latter protons are split into a quartet (not always well resolved). The corresponding carbon resonance of CF~3~ is located between 120.2 and 121.2 ppm with the relevant ^1^ *J*(C,F) coupling constants being approximately 270 Hz (269.6--270.6 Hz). As well, the signal of C-3 is always split into a quartet (*J* \~ 40 Hz) due to the ^2^ *J*(C,F~3~) coupling.

As the ^15^N NMR chemical shifts were determined by ^15^N,^1^H HMBC experiments the resonance of (pyrazole) N-2 was not captured owing to the fact that this nitrogen atom lacks of sufficient couplings to protons, thus disabling the necessary coherence transfer (^19^F,^15^N HMBC spectra were not possible with the equipment at hand). For N-1, with pyrazole derivatives **4** and **6** remarkably larger ^15^N chemical shifts were detected (−158.8 to −160.2 ppm) compared to the corresponding signals for pyrazolopyridines **5** and **7** (−182.2 to −185.9 ppm). When switching from an azine to an azine oxide partial structure (**5**→**7**) the N-5 resonance exhibits an explicit upfield shift (15.6--18.3 ppm), being typical for the changeover from pyridine to pyridine *N*-oxide \[[@R33]\].

NMR experiments also allowed the determination of the stereochemistry of oximes **6**: considering the size of ^1^ *J*(N=C-H) which is strongly dependent on lone-pair effects \[[@R34]\] as well as the comparison of chemical shifts with those of related, unambiguously assigned oximes \[[@R17]\] reveals *E*-configuration at the C=N double bond.

With byproduct **8a** the position of the carbonyl group unequivocally follows from the correlations between phenyl protons and the carbonyl C-atom and, reversely, from those between the methylene protons with pyrazole C-4 and pyrazole C-5 (determined by ^13^C,^1^H HMBC).

In [Fig. 2](#F2){ref-type="fig"} essential NMR data for the complete series of type **c** (**4c**, **5c**, **6c**, **7c**) are displayed, which easily enables to compare the notable chemical shifts and allows following the trends described above.

![^1^H (in italics, red), ^13^C (black), ^15^N (in blue) and ^19^F NMR (green) chemical shifts of compounds **4c**, **5c**, **6c** and **7c** (in CDCl~3~).](Beilstein_J_Org_Chem-10-1759-g003){#F2}

Full experimental details as well as spectral and microanalytical data of the obtained compounds are presented in [Supporting Information File 1](#SD1){ref-type="supplementary-material"}.

Conclusion
==========

To sum up, the presented approach represents a simple method for the synthesis of 6-substituted 1-phenyl-3-trifluoromethyl-1*H*-pyrazolo\[4,3-*c*\]pyridines **5** and the analogous 5-oxides **7** starting from commercially available 1-phenyl-3-trifluoromethyl-1*H*-pyrazol-5-ol (**1**). In the case of the former (**5**) the described multicomponent reaction approach is superior compared to the sequential one, whereas the step-by-step synthesis of *N*-oxides **7** is still characterized by higher overall yields. In addition, in-depth NMR studies with all synthesized compounds were performed, affording full and unambiguous assignment of ^1^H, ^13^C, ^15^N and ^19^F resonances and the designation of ascertained heteronuclear spin-coupling constants.
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Experimental details and characterization data.
